When fibrinogen was used as antigen, autoantibodies from pooled SF from RA patients reacted equally well with PAD2- and PAD4-citrullinated fibrinogen, at any SF dilution employed and at any PAD concentration used for citrullination. This evidence concerns the gene PADI4 and rheumatoid arthritis.